Full-length ALK is expressed in neuroblastoma [84], and is a fairly frequent target of genetic alterations leading to activating mutations in cases of both familial (1–2%) and sporadic (6–10%) primary neuroblastoma [[85], [86], [87], [88]]. Here, ALK is linked to neuroblastoma.